Kleinberg et al. [20] measured the serum prolactin level in patients with schizophrenia during RIS or HPD therapy and also found that the serum prolactin level was higher in females than in males, although the values for both sexes were higher than in the placebo group, regardless of dose. Here, PRL is linked to schizophrenia.